These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36293511)

  • 21. Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis development.
    Niwa H; Kanno Y; Shu E; Seishima M
    Mol Med Rep; 2020 Oct; 22(4):3001-3007. PubMed ID: 32945390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
    Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
    Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X; Tan FK; Guo X; Arnett FC
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment.
    Pasquali Ronchetti I; Guerra D; Quaglino D; Vincenzi D; Manzini E; Canossi B; Manzini CU
    Clin Exp Rheumatol; 1989; 7(4):373-83. PubMed ID: 2591110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts.
    Farina G; Lemaire R; Korn JH; Widom RL
    Matrix Biol; 2006 May; 25(4):213-22. PubMed ID: 16520029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.
    Song Y; Zhu L; Li M
    Clinics (Sao Paulo); 2013 Oct; 68(10):1350-7. PubMed ID: 24212843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
    Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
    Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Aquaporin3 in Systemic Sclerosis Dermal Fibroblasts.
    Yousefi B; Mahmoudi M; Sarafnejad A; Karimizadeh E; Farhadi E; Jamshidi AR; Kavosi H; Aslani S; Gharibdoost F
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):228-234. PubMed ID: 28732436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.
    Rosenbloom J; Saitta B; Gaidarova S; Sandorfi N; Rosenbloom JC; Abrams WR; Hamilton AD; Sebti SM; Kucich U; Jimenez SA
    Arthritis Rheum; 2000 Jul; 43(7):1624-32. PubMed ID: 10902768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta.
    Rudnicka L; Varga J; Christiano AM; Iozzo RV; Jimenez SA; Uitto J
    J Clin Invest; 1994 Apr; 93(4):1709-15. PubMed ID: 7512991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY; Finnson KW; Baron M; Philip A
    Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis.
    Khan L; Derksen T; Redmond D; Storek J; Durand C; Gniadecki R; Korman B; Cohen Tervaert JW; D'Aubeterre A; Osman MS; Willis LM
    J Autoimmun; 2023 Nov; 140():103110. PubMed ID: 37742510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.
    Kudo H; Jinnin M; Asano Y; Trojanowska M; Nakayama W; Inoue K; Honda N; Kajihara I; Makino K; Fukushima S; Ihn H
    Arthritis Rheumatol; 2014 Jun; 66(6):1636-47. PubMed ID: 24470401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis.
    Kanno Y; Shu E; Kanoh H; Seishima M
    J Invest Dermatol; 2016 Apr; 136(4):762-769. PubMed ID: 26743600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.